Mark Haden
Corporate Officer/Principal chez CLEARMIND MEDICINE INC.
Fortune : 150 $ au 31/05/2024
Postes actifs de Mark Haden
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CLEARMIND MEDICINE INC. | Corporate Officer/Principal | 01/07/2021 | - |
Historique de carrière de Mark Haden
Anciens postes connus de Mark Haden
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Psygen Labs, Inc.
 Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka. | Corporate Officer/Principal | 01/04/2021 | 01/03/2022 |
Formation de Mark Haden
| University of British Columbia | Graduate Degree |
Statistiques
Internationale
| Canada | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLEARMIND MEDICINE INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Psygen Labs, Inc.
Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka. | Health Technology |
- Bourse
- Insiders
- Mark Haden
- Expérience
